Immune tolerance induction (ITI) with a FVIII concentrate with high VWF content in inhibitor patients with previous unsuccessful ITI and/or negative predictors of ITI response

被引：0
|
作者：
Coppola, A. [1 ]
Arbasi, M. [2 ]
Biasoli, C. [3 ]
Messina, M. [4 ]
Tagliaferri, A. [5 ]
Scaraggi, F. [6 ]
机构：
[1] Federico II Univ Hosp, Reg Reference Ctr Coagulat Disorders, Milan, Italy
[2] Hosp Piacenza, Ctr Bleeding Disorders, Piacenza, Italy
[3] Bufalini Hosp, Transfus & Haemophilia Ctr, Cesena, Italy
[4] Regina Margherita Children Hosp, Paediat Reg Reference Ctr Bleeding & Thrombot Dis, Turin, Italy
[5] Univ Hosp, Reg Reference Ctr Haemophilia, Parma, Italy
[6] Univ Bari, Dept Internal Med, Haemostasis & Thrombosis Ctr, Bari, Italy
来源：
HAEMOPHILIA | 2010年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：70 / 71
页数：2
相关论文
共 50 条
  • [41] Immune Tolerance Induction (ITI) with a Plasma-Derived Factor VIII for Patients with Hemophilia a and Inhibitors: A Retrospective Study
    Escobar, Miguel A.
    Shaffer, Linda
    Holguin, Mark
    McCavit, Timothy
    Rajan, Sandeep K.
    Amega, Novinyo
    BLOOD, 2019, 134
  • [42] Immune tolerance induction (ITI) in patients with hemophilia A and inhibitors: the Italian retrospective-prospective registry - the PROFIT study
    Santagostino, E.
    Coppola, A.
    Rocino, A.
    Mancuso, M.
    Tagliaferri, A.
    Scaraggi, F.
    Biasoli, C.
    Messina, M.
    Iorio, A.
    Mancuso, G.
    HAEMOPHILIA, 2008, 14 : 57 - 57
  • [43] Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study
    Jimenez-Yuste, V.
    Oldenburg, J.
    Rangarajan, S.
    Peiro-Jordan, R.
    Santagostino, E.
    HAEMOPHILIA, 2016, 22 (06) : 859 - 865
  • [44] Immune tolerance induction (ITI) according to the Bonn protocol in haemophilia A patients with inhibitors using a plasma-derived VWF-containing factor VIII concentrate: two paediatric case reports
    Lohse, J.
    Gehrisch, S.
    Escuriola-Ettingshausen, C.
    Kreuz, W.
    Knoefler, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1073 - 1074
  • [45] Immune Tolerance Induction (ITI) With Factor IX and Combined Immunosuppressive Therapy in two Patients With Severe Haemophilia B, Longstanding Inhibitors and Previous Allergic Reactions
    Holstein, K.
    Voigtlaender, M.
    Dicke, C.
    Langer, F.
    HAEMOPHILIA, 2017, 23 : 93 - 93
  • [46] IMMUNE TOLERANCE INDUCTION RESCUE (ITI-R) WITH HUMAN-CL RHFVIII IN HEMOPHILIA A PATIENTS AND HIGH-TITRE INHIBITORS
    Zanon, E.
    Pasca, S.
    Pollio, B.
    Ricca, I.
    Marino, R.
    HAEMATOLOGICA, 2019, 104 : 19 - 19
  • [47] Progress report on the experience of immune tolerance induction with a VWF/FVIII concentrate in haemophilia a patients in Colombia
    Montano, C.
    David, G.
    Rueda, E.
    Estupinan, D.
    Maza, A.
    De Los Reyes, I
    Martinez, L.
    Gutierrez, C.
    Escuriola, C.
    Kreuz, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1077 - 1077
  • [48] Factor VIII gene (F8) mutations as a predictor of outcome in immune tolerance induction (ITI) in hemophilia A patients with high-responding inhibitors
    Coppola, A.
    Margaglione, M.
    Santagostino, E.
    Rocino, A.
    Scaraggi, F.
    Tagliaferri, A.
    Castaman, G.
    Messina, M.
    Mancuso, M. E.
    Iorio, A.
    Schinco, P.
    Zanon, E.
    Musso, R.
    Mancuso, G.
    Di Minno, G.
    Mannucci, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 191 - 192
  • [49] Real-World Data of Immune Tolerance Induction Using rFVIIIFc in Subjects With Severe Hemophilia A With Inhibitors at High Risk for ITI Failure
    Carcao, Manuel
    Shapiro, Amy
    Hwang, Nina
    Pipe, Steven
    Ahuja, Sanjay
    Lieuw, Kenneth
    Staber, Janice
    Sun, Haowei Linda
    Ding, Hilda
    Wang, Michael
    Steele, Macgregor
    Tsao, Elisa
    Feng, Jing
    Al-Khateeb, Zahra
    Dumont, Jennifer
    Jain, Nisha
    BLOOD, 2018, 132
  • [50] IMPACT OF FACTOR VIII GENE (F8) MUTATION ON IMMUNE TOLERANCE INDUCTION (ITI) OUTCOMES IN HAEMOPHILIA A PATIENTS WITH INHIBITORS IN THE OBSITI STUDY
    Pavlova, A.
    Escuriola-Ettingshausen, C.
    Oldenburg, J.
    HAEMOPHILIA, 2020, 26 : 54 - 54
12345